60 Degrees Pharmaceuticals (SXTP) Other Gross PP&E Adjustments (2022 - 2025)
60 Degrees Pharmaceuticals (SXTP) has disclosed Other Gross PP&E Adjustments for 4 consecutive years, with $397683.0 as the latest value for Q3 2025.
- On a quarterly basis, Other Gross PP&E Adjustments rose 63.36% to $397683.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $397683.0, a 63.36% increase, with the full-year FY2024 number at $257411.0, up 161.93% from a year prior.
- Other Gross PP&E Adjustments was $397683.0 for Q3 2025 at 60 Degrees Pharmaceuticals, up from $353889.0 in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $397683.0 in Q3 2025 to a low of $42167.0 in Q2 2023.
- A 4-year average of $204461.4 and a median of $243441.0 in 2024 define the central range for Other Gross PP&E Adjustments.
- Peak YoY movement for Other Gross PP&E Adjustments: dropped 9.41% in 2023, then surged 477.33% in 2024.
- 60 Degrees Pharmaceuticals' Other Gross PP&E Adjustments stood at $108485.0 in 2022, then fell by 9.41% to $98274.0 in 2023, then skyrocketed by 161.93% to $257411.0 in 2024, then soared by 54.49% to $397683.0 in 2025.
- Per Business Quant, the three most recent readings for SXTP's Other Gross PP&E Adjustments are $397683.0 (Q3 2025), $353889.0 (Q2 2025), and $310016.0 (Q1 2025).